Alberta and Varian, Inc. collaborate on disease diagnosis research
Government funds second phase of the Magnetic Resonance Diagnostics Centre
Alberta's Magnetic Resonance Diagnostics Centre at the University of Alberta is getting a boost for continuing collaborative disease diagnosis research using the emerging science of metabolomics. The Alberta government and Varian, Inc. are extending their research agreement to study metabolomic profiles associated with disease.
A memorandum of understanding was signed which builds on a prior investment by the Alberta government and the University of Alberta to establish the Magnetic Resonance Diagnostic Centre.
The Centre was created in 2004 to research diseases using the emerging science of metabolomics. Metabolomics uses nuclear magnetic resonance (NMR) spectroscopy applied to body fluids such as blood and urine to determine the flux of metabolites in the human body in response to systemic stresses that occur during illness or in reaction to drug intake.
The Centre is receiving $1.5 million in funding to provide Albertans with faster and more accurate diagnosis of diseases such as pneumonia and asthma. The extension of this agreement continues the collaboration that began in 2004 between the Alberta government and Varian, Inc. in funding the diagnostics centre. The Alberta government is contributing $400,000 and Varian, Inc. is supporting the project with in kind contributions, as well as leveraging its relationships with other industry partners to further the development of NMR spectroscopy with relation to metabolite research. The remaining project support will come from other industry and government partners.
Most read news
Topics
Organizations
Other news from the department science
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
See the theme worlds for related content
Topic World Spectroscopy
Investigation with spectroscopy gives us unique insights into the composition and structure of materials. From UV-Vis spectroscopy to infrared and Raman spectroscopy to fluorescence and atomic absorption spectroscopy, spectroscopy offers us a wide range of analytical techniques to precisely characterize substances. Immerse yourself in the fascinating world of spectroscopy!
Topic World Spectroscopy
Investigation with spectroscopy gives us unique insights into the composition and structure of materials. From UV-Vis spectroscopy to infrared and Raman spectroscopy to fluorescence and atomic absorption spectroscopy, spectroscopy offers us a wide range of analytical techniques to precisely characterize substances. Immerse yourself in the fascinating world of spectroscopy!
Last viewed contents
Opening the cavity floodgates - Biochemists investigate the transport of large proteins through bacterial cell membranes
Watermelon genome decoded - Decoded genome paves way for better watermelons
BIO White Paper Dispels Over-Patenting Myth - Patenting is a Critical Element in Fostering Research and Development
Dow acquires Rohm and Haas, creating world's leading specialty chemicals and advanced materials company - $18.8 billion transaction marks pivotal point in Dow's transformation
Cells stop dividing when this gene kicks into high gear
Targeted test for antibiotic resistance in clinical Enterobacter species - New discovery enables targeted antibiotic therapy
Varian, Inc. Announces Unique Probe Technology Breakthrough for Biological Solids NMR
Breakthrough Discovery Sheds Light on Heart and Muscle Health - Scientists shoot first true-to-life 3D image of the thick filament of mammalian heart muscle
Diagnosis just a breath away with new laser
MIT nanotubes sniff out cancer agents in living cells - Chemical engineers use carbon nanotubes to monitor chemotherapy, detect toxins at the single-molecule level